drugset / Trial / NCT06849544
Phase II Trial to Investigate the Safety and Efficacy of Four Dosing Regimens of OTL78 Injection
Phase 2
Recruiting
22 enrolled
Clinton Bahler
Indiana University · collabOn Target Laboratories, LLC · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
This study is being done to compare how well Zopocianine (OTL78) in combination with Near InfraRed (NIR) fluorescent imaging may improve the detection of malignant (growing in an uncontrolled way) tissue in adult subjects undergoing prostatectomy and lymph node dissection for biopsy confirmed prostate cancer.
Timeline
- Start
- 2025-04-02
- Primary completion
- 2026-07
- Completion
- 2026-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zopocianine | Small molecule | 0.03 mg/kg | — |
| Subject | Zopocianine | Small molecule | 0.06 mg/kg | — |